Interestingly, retinoic acid treatment of neuroblastoma cells revealed downregulation of IGF2BP3, and evidence within our laboratory shows this is also the case for IGF2BP1 (Bell et al., unpublished). This evidence concerns the gene IGF2BP3 and neuroblastoma.